— Know what they know.
Not Investment Advice

NKTX NASDAQ

Nkarta, Inc.
1W: +7.8% 1M: -1.9% 3M: +30.0% YTD: +50.8% 1Y: +78.2% 3Y: -19.2% 5Y: -90.6%
$3.03
+0.00 (+0.00%)
 
Weekly Expected Move ±10.0%
$2 $2 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 48 · $216.8M mcap · 54M float · 1.52% daily turnover · Short 36% of daily vol

Cash Flow Trends

Operating Cash Flow
-$89M +11.0% ▲
Capital Expenditures
$1M +72.6% ▲
5Y CAGR: -30.6%
Free Cash Flow
-$90M +13.6% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$12M +471.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$86M-$114M-$118M-$109M-$104M
Depreciation & Amort.$2M$3M$6M$2M$5M
Stock-Based Comp.$14M$17M$17M$17M$9M
Change in Working Capital-$2M$34M$11M-$12M-$435K
Other Non-Cash Items$337K$4M-$3M$2M$3M
Operating Cash Flow-$68M-$57M-$86M-$100M-$89M
— Investing Activities —
Capital Expenditures-$5M-$47M-$28M-$4M-$1M
Acquisitions (Net)-$38K$138K$0$0$0
Investment Purchases-$227M-$386M-$260M-$406M-$239M
Investment Sales$265M$248M$367M$281M$340M
Other Investing$38K-$138K$0$0$0
Investing Cash Flow$33M-$185M$79M-$130M$100M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$2M$0$1M$0
Financing Cash Flow$1M$219M$691K$226M$141K
Net Change in Cash-$34M-$23M-$6M-$3M$12M
Cash End of Period$63M$40M$34M$31M$42M
Free Cash Flow-$73M-$104M-$114M-$104M-$90M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms